BACKGROUND AND OBJECTIVES: Meningiomas in children are uncommon, with distinct characteristics that set them apart from their adult counterparts. The existing evidence for stereotactic radiosurgery (SRS) in this patient population is limited to only case series. The objective of this study was to evaluate the safety and efficacy of SRS in managing pediatric meningiomas. METHODS: Children and adolescents who had been treated for meningioma with single-fraction SRS were included in this retrospective, multicenter study. The assessment included local tumor control, any complications related to the tumor or SRS, and the emergence of new neurological deficits after SRS. RESULTS: The cohort included 57 patients (male-to-female ratio 1.6:1) with a mean age of 14.4 years who were managed with single-fraction SRS for 78 meningiomas. The median radiological and clinical follow-up periods were 69 months (range, 6-268) and 71 months (range, 6-268), respectively. At the last follow-up, tumor control (tumor stability and regression) was achieved in 69 (85.9%) tumors. Post-SRS, new neurological deficits occurred in 2 (3.5%) patients. Adverse radiation effects occurred in 5 (8.8%) patients. A de novo aneurysm was observed in a patient 69 months after SRS. CONCLUSION: SRS seems to be a safe and effective up-front or adjuvant treatment option for surgically inaccessible, recurrent, or residual pediatric meningiomas.
Introduction: Magnetic resonance imaging (MRI) is a robust neuroimaging technique and is the preferred method for stereotactic radiosurgery (SRS) planning. However, MRI data always contain distortions caused by hardware and patient factors. Research question: Can these distortions potentially compromise the effectiveness and safety of SRS treatments? Material and methods Twenty-six MR datasets with multiple metastatic brain tumors (METs) used for Gamma Knife radiosurgery (GKRS) were retrospectively evaluated. A commercially available software was used for distortion correction. Geometrical agreement between corrected and uncorrected tumor volumes was evaluated using MacDonald criteria, Euclidian distance, and Dice similarity coefficient (DSC). SRS plans were generated using uncorrected tumor volumes, which were assessed to determine their coverage of the corrected tumor volumes. Results: The median target volume was 0.38 cm3 (range,0.01–12.38 cm3). A maximum displacement of METs of up to 2.87 mm and a median displacement of 0.55 mm (range,0.1–2.87 mm) were noted. The median DSC between uncorrected and corrected MRI was 0.92, and the most concerning case had a DSC of 0.46. Although all plans met the optimization criterion of at least 98% of the uncorrected tumor volume (median 99.55%, range 98.1–100%) receiving at least 100% of the prescription dose, the percent of the corrected tumor volume receiving the total prescription dose was a median of 95.45% (range,23.1–99.5%). Discussion and conclusion MRI distortion, though visually subtle, has significant implications for SRS planning. Regular utilization of corrected MRI is recommended for SRS planning as distortion is sometimes enough to cause a volumetric miss of SRS targets.
Background/Objectives: LINAC-based single-isocenter (SIT) stereotactic radiosurgery (SRS) enables efficient treatment of multiple brain metastases but may compromise target conformity and increase low-dose brain exposure, particularly for spatially distributed lesions. Dual-isocenter techniques (DITs) may mitigate these limitations, while Gamma Knife (GK) remains the reference standard for high-selectivity radiosurgery. This study compares SIT- and DIT LINAC-based SRS with GK, focusing on target conformity and low-dose brain exposure under equivalent, zero-margin targeting assumptions. Methods: Twenty-eight patients with multiple brain metastases (197 lesions) were included in this retrospective planning study. For each patient, three plans were generated: a GK plan and LINAC-based SIT and DIT plans using automated dynamic conformal arc optimization (Elements Multiple Brain Metastases). All plans were generated using a zero-millimeter GTV-to-PTV margin strategy. For DIT, lesions were automatically clustered and assigned to two isocenters. Target coverage required ≥99% of each GTV to receive the prescription dose. Plan quality was evaluated using the Paddick Conformity Index (PCI) on a per-lesion basis and low-dose brain volumes (V12, V10, V5, V4, and V3 Gy) on a per-patient basis. Paired non-parametric tests and multivariable models were used to assess technique-related differences and associations with total target volume and lesion count. Results: GK achieved the highest median PCI (0.83), followed closely by DIT (0.77), while SIT plans demonstrated significantly lower conformity (0.73). Compared with GK, the median PCI difference was −0.05 for DIT and −0.08 for SIT. Conformity for DIT remained stable across lesion volumes and lesion counts, whereas GK conformity increased modestly with lesion size. Low-dose brain exposure differed significantly between techniques at all dose levels (p < 0.001). GK consistently yielded the lowest Vx volumes, SIT the highest, and DIT intermediate values. Relative to GK, SIT plans showed progressively larger increases in low-dose exposure at lower dose levels (mean ΔV3 ≈ +149 cc), while DIT reduced this low-dose spread (mean ΔV3 ≈ +117 cc). Total target volume was the dominant predictor of low-dose brain exposure across all techniques, with a smaller additional contribution from lesion count. Conclusions: DIT LINAC-based SRS significantly improves target conformity and reduces low-dose brain exposure compared with SIT delivery, achieving dosimetric performance that closely approximates Gamma Knife under equivalent zero-margin targeting assumptions. While Gamma Knife remains the reference standard for low-dose sparing, dual-isocenter planning represents a clinically robust and scalable alternative that effectively balances plan quality and treatment efficiency in patients with multiple brain metastases.
Stereotactic radiosurgery (SRS) is a potential treatment for trigeminal neuralgia (TN) secondary to arteriovenous malformations (AVMs), though its efficacy and safety remain unclear due to the rarity of this condition. We analyzed 1211 brain AVM cases treated with Gamma Knife radiosurgery (GKRS) between 2005 and 2023 at our institution. Four patients (0.33%) were presented with TN secondary to AVM. Three patients received single-fraction GKRS while one underwent hypofractionated treatment. Treatment outcomes were assessed using magnetic resonance imaging, digital subtraction angiography, and the Barrow Neurological Institute pain intensity scale. The mean marginal dose and AVM volume were 21.5 Gy and 0.58 cc, respectively. The mean follow-up period was 85.75 months. Complete AVM obliteration was achieved in all patients, with all experiencing complete pain relief within a mean time of 18 months, enabling gradual discontinuation of medications. No radiation-related adverse effects were observed. Our literature review identified only 15 previously reported cases where SRS was used as primary treatment for TN secondary to AVM, with most cases showing favorable outcomes in pain relief and AVM obliteration. This study is the first case series to demonstrate the sole use and efficacy of GKRS in managing TN secondary to AVM, moving beyond individual case reports. SRS appears to be a safe and effective primary treatment option for TN secondary to AVM, particularly when conventional surgical approaches are contraindicated or pose excessive risks. The sustained pain relief and absence of complications in our series, combined with previous case reports, support its use in managing this rare condition.